Literature DB >> 9108985

Defining outcomes in older patients with cardiovascular disease.

C L Pashos1.   

Abstract

It is now possible to track a comprehensive range of outcomes in elderly cardiac patients. Beside vital clinical end-points, these include health-related quality of life, satisfaction with care, and economic outcomes. This range of outcomes, each set complementing the others, can support patient care that is more effective from both the physician's and the patient's perspective. In this summary article, quality of life, satisfaction and economic outcomes are explored relative to the treatment of elderly cardiac patients. This is not meant to diminish the importance of the clinical measures that can and must be readily appreciated by physicians managing their cardiac patients. Instead, the measures discussed here augment the armamentarium that physicians can use to implement their patient care responsibilities.

Entities:  

Mesh:

Year:  1997        PMID: 9108985     DOI: 10.2165/00002512-199710040-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  36 in total

1.  Assessing quality of life after surgery.

Authors:  P D Cleary; S Greenfield; B J McNeil
Journal:  Control Clin Trials       Date:  1991-08

Review 2.  Patient satisfaction as an indicator of quality care.

Authors:  P D Cleary; B J McNeil
Journal:  Inquiry       Date:  1988       Impact factor: 1.730

3.  The Functional Status Questionnaire: reliability and validity when used in primary care.

Authors:  A M Jette; A R Davies; P D Cleary; D R Calkins; L V Rubenstein; A Fink; J Kosecoff; R T Young; R H Brook; T L Delbanco
Journal:  J Gen Intern Med       Date:  1986 May-Jun       Impact factor: 5.128

4.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

5.  Development and testing of a new measure of health status for clinical trials in heart failure.

Authors:  G H Guyatt; S Nogradi; S Halcrow; J Singer; M J Sullivan; E L Fallen
Journal:  J Gen Intern Med       Date:  1989 Mar-Apr       Impact factor: 5.128

6.  Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction.

Authors:  A S Midgette; J B Wong; J R Beshansky; A Porath; C Fleming; S G Pauker
Journal:  Med Decis Making       Date:  1994 Apr-Jun       Impact factor: 2.583

7.  Quality of life after myocardial infarction.

Authors:  T K Hillers; G H Guyatt; N Oldridge; J Crowe; A Willan; L Griffith; D Feeny
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

8.  Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

Authors:  L Goldman; M C Weinstein; P A Goldman; L W Williams
Journal:  JAMA       Date:  1991-03-06       Impact factor: 56.272

9.  Cost-effectiveness of routine coronary angiography after acute myocardial infarction.

Authors:  K M Kuntz; J Tsevat; L Goldman; M C Weinstein
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

10.  Analysis of quality of life data from a randomized, placebo-controlled heart-failure trial.

Authors:  P K Tandon; H Stander; R P Schwarz
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.